Highly rated in
Highly rated in
Check Dr. Jessica K. Gordon's experience treating your condition:
About Dr. Jessica K. Gordon

Jessica Gordon is a Rheumatologist in New York, New York. Gordon has been practicing medicine for over 21 years and is highly rated in 16 conditions, according to our data. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Localized Scleroderma. She is licensed to treat patients in New York.

Her clinical research consists of co-authoring 84 peer reviewed articles and participating in 11 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Jessica K. Gordon it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
525 E 71st St, 7th Floor, New York, NY 10021
Other Locations
525 E 70th St, New York, NY 10065
Background & Education
Graduate Institution
State University Of New York At Stony Brook, School Of Medicine, 2002
Internal Medicine in NY
Hospital Affiliations
Hospital For Special Surgery
NewYork-Presbyterian/Weill Cornell Medical Center
Bergen New Bridge Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

The Scleroderma Registry & Repository
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
A Phase II Multi-center Study of High-Dose Cyclophosphamide and Antithymocyte Globulin Followed by Autologous Hematopoietic Cell Transplantation With Post Transplant Maintenance for the Treatment of Systemic Sclerosis
Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease
View 7 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors